Real-time enrollment status for this pik3ca overgrowth spectrum clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 11:01 AM UTC
| NCT Number | NCT06789913 |
| Recruiting Status | Recruiting |
| Condition | PIK3CA Overgrowth Spectrum |
| Phase | PHASE2 |
| Target Enrollment | 277 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Relay Therapeutics, Inc. |
| Last Updated on CT.gov | June 12, 2026 (Jun 12, 2026) |
As of July 20, 2026: Clinical trial NCT06789913 is currently recruiting participants. This phase2 study for pik3ca overgrowth spectrum is actively seeking new participants at 20 locations across the United States. The study is sponsored by Relay Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06789913 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06789913 was last updated Jun 12, 2026 (June 12, 2026). HelloStudys verifies this status automatically.